Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Mi-Kyung Hong Department of
Clinical Pharmacy and Institute for Health Policy Studies, University
of California, Box 0613, San Francisco, CA 94143-0613, USA Correspondence to:
L A Bero Bero@medicine.ucsf.edu
| The first 150 words of the full text of this article appear below. |
In 1981 an influential Japanese study showed an association between passive smoking and lung cancer. This article documents the tobacco industry's attempts to refute this study by producing a credible alternative study
In 1981 Japanese investigator Takeshi Hirayama published a cohort study examining the association of passive smoking and lung cancer among non-smoking wives of smokers in Japan.1 The study concluded that wives of heavy smokers had up to twice the risk of developing lung cancer as wives of non-smokers and that the risk was dose related. The Hirayama study was influential because it launched an extraordinary amount of critical debate 2 3 and has been one of the most frequently cited studies in regulatory proceedings, 4 5 risk assessments,6 and the media.7
The tobacco industry has used a variety of tactics to maintain
scientific debate about whether secondhand smoke has any harmful effects.
5 6 8-14
We identify and analyse internal
tobacco industry documents that describe the industry's
Read all Rapid Responses